Naphtho[1',2':4,5]imidazo[1,2-a]pyridine-5,6-diones: Synthesis, enzymatic reduction and cytotoxic activity.

[1]  Wuxia Zhang,et al.  Unveiling the Mode of Action of Two Antibacterial Tanshinone Derivatives , 2015, International journal of molecular sciences.

[2]  Q. You,et al.  Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1). , 2015, Bioorganic & medicinal chemistry letters.

[3]  Kevin W. Wellington.  Understanding cancer and the anticancer activities of naphthoquinones – a review , 2015 .

[4]  Shuangping Liu,et al.  Clinical implications of high NQO1 expression in breast cancers , 2014, Journal of experimental & clinical cancer research : CR.

[5]  T. Grigliatti,et al.  A Correlation between Cytotoxicity and Reductase-Mediated Metabolism in Cell Lines Treated with Doxorubicin and Daunorubicin , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[6]  G. Peters,et al.  EO9 (Apaziquone): from the clinic to the laboratory and back again , 2013, British journal of pharmacology.

[7]  Sung-Hoon Kim,et al.  Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities , 2012, International journal of molecular sciences.

[8]  L. Costa-Lotufo,et al.  Growth inhibitory effects of 3'-nitro-3-phenylamino nor-beta-lapachone against HL-60: a redox-dependent mechanism. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  Shih-Chieh Lin,et al.  Abstract 3083: Dual-specificity phosphatase-2 (DUSP2) negatively control cyclooxygenase-2 (COX-2) expression in cancer cells , 2012 .

[10]  P. Hergenrother,et al.  Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death. , 2010, Journal of the American Chemical Society.

[11]  D. Ross,et al.  Enzymatic Reduction and Glutathione Conjugation of Benzoquinone Ansamycin Heat Shock Protein 90 Inhibitors: Relevance for Toxicity and Mechanism of Action , 2008, Drug Metabolism and Disposition.

[12]  Jin Sung Kim,et al.  Synthesis of 1-/2-substituted-[1,2,3]triazolo[4,5-g]phthalazine-4,9-diones and evaluation of their cytotoxicity and topoisomerase II inhibition. , 2008, Bioorganic & medicinal chemistry.

[13]  J. Minna,et al.  An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone , 2007, Proceedings of the National Academy of Sciences.

[14]  M. Devereux,et al.  In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines. , 2006, Chemico-biological interactions.

[15]  S. White,et al.  Structural and Mechanistic Studies of Escherichia coli Nitroreductase with the Antibiotic Nitrofurazone , 2005, Journal of Biological Chemistry.

[16]  L. Martinez,et al.  Quinones as antimycobacterial agents. , 2004, Bioorganic & medicinal chemistry.

[17]  Sang Woo Park,et al.  Synthesis and cytotoxicity of 1-substituted 2-methyl-1H-imidazo[4,5-g]phthalazine-4,9-dione derivatives. , 2004, Bioorganic & medicinal chemistry.

[18]  E. Novellino,et al.  New benzo[g]isoquinoline-5,10-diones and dihydrothieno [2,3-b]naphtho-4,9-dione derivatives: synthesis and biological evaluation as potential antitumoral agents. , 2003, Bioorganic & medicinal chemistry.

[19]  D. Schollmeyer,et al.  Synthesis and cytotoxicity of 6,11-dihydro-pyrido- and 6,11-dihydro-benzo[2,3-b]phenazine-6,11-dione derivatives. , 2003, Bioorganic & medicinal chemistry.

[20]  N. Čėnas,et al.  Two-electron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structure-activity relationships. , 2002, Archives of biochemistry and biophysics.

[21]  A. Brandelli,et al.  In vitro antimicrobial activity of a new series of 1,4-naphthoquinones. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  D. Roop,et al.  NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. , 2001, Journal of the National Cancer Institute.

[23]  A. Bolzán,et al.  Genotoxicity of streptonigrin: a review. , 2001, Mutation research.

[24]  D. Ross,et al.  NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. , 2000, Chemico-biological interactions.

[25]  P. Gutiérrez.  The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review. , 2000, Free radical biology & medicine.

[26]  L. Amzel,et al.  Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Bolton,et al.  Role of quinones in toxicology. , 2000, Chemical research in toxicology.

[28]  M. M. Cowan.  Plant Products as Antimicrobial Agents , 1999, Clinical Microbiology Reviews.

[29]  G. Peters,et al.  DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents? , 1995, British Journal of Cancer.

[30]  A. Archakov,et al.  The electron transfer reactions of NADPH: cytochrome P450 reductase with nonphysiological oxidants. , 1994, Archives of biochemistry and biophysics.

[31]  J. Verweij,et al.  Mitomycin C. , 1990, Cancer chemotherapy and biological response modifiers.

[32]  G. Powis,et al.  Cytosolic NAD(P)H:(Quinone‐acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol , 1990, International journal of cancer.

[33]  R. Mason,et al.  Correlation of kinetic parameters of nitroreductase enzymes with redox properties of nitroaromatic compounds. , 1989, The Journal of biological chemistry.

[34]  R. Marcus,et al.  Electron transfers in chemistry and biology , 1985 .

[35]  N. Čėnas,et al.  Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity. , 2006, Acta biochimica Polonica.

[36]  Shiuan Chen,et al.  Quinone reductase-mediated nitro-reduction: clinical applications. , 2004, Methods in enzymology.

[37]  A. Maran,et al.  DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours. , 1997, British Journal of Cancer.

[38]  P. O'Brien.  Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.

[39]  P. Wardman.  Bioreductive activation of quinones: redox properties and thiol reactivity. , 1990, Free radical research communications.

[40]  E. Cadenas,et al.  Effect of superoxide dismutase on the autoxidation of hydroquinones formed during DT-diaphorase catalysis and glutathione nucleophilic addition. , 1990, Advances in experimental medicine and biology.